Evaluation of One Hundred and Fifteen Cases Followed up with the Diagnosis of Leptospirosis
PDF
Cite
Share
Request
Original Article
P: 9-13
April 2024

Evaluation of One Hundred and Fifteen Cases Followed up with the Diagnosis of Leptospirosis

J Eur Med Sci 2024;5(1):9-13
1. Clinic of Infectious Diseases and Clinical Microbiology University of Health Sciences Turkey, Adana City Training and Research Hospital, Adana, Türkiye
2. Clinic of Infectious Diseases and Clinical Microbiology Bayrampaşa State Hospital, İstanbul, Türkiye
No information available.
No information available
Received Date: 29.05.2024
Accepted Date: 29.07.2024
Online Date: 15.08.2024
Publish Date: 05.09.2024
PDF
Cite
Share
Request

ABSTRACT

Objective

This study was conducted to investigate the clinical, laboratory, and epidemiological characteristics of 115 patients who were followed up with the diagnosis of leptospirosis.

Material and Methods

The study was conducted the study was conducted retrospectively and descriptively. In total, 115 cases of leptospirosis were analyzed retrospectively. The microagglutination test was used for disease serodiagnosis. The data were analyzed using the SPSS-22 package.

Results

The mean age of the patients was 29.4 years (minimum: 10, maximum: 65), and 96 (83.5%) can be deleted were men. 43.6% (n=50) of the patients were hospitalized. Five hospitalized patients were followed up in the intensive care unit. The disease was not fatal. All patients presented with fever. Hepatomegaly was the most common sign 31.3% (n=36). Thrombocytopenia occurs in 73% of patients, and it is the most important laboratory finding. The most important finding of our study was that no deaths were observed in these cases.

Conclusion

The coincidence of patient presentation to the epidemic period, consideration of leptospirosis in the differential diagnosis, and early commencement of antibiotic therapy were thought to contribute to the lack of deaths. The younger age of patients in our study may be another reason for the lack of mortality. Leptospirosis remains a common zoonosis in tropical regions, particularly among agricultural irrigation workers. Considering the clinical and serological diagnosis of leptospirosis, initiating antibiotherapy early is of vital importance because it will reduce mortality.

INTRODUCTION

Leptospirosis is an acute, febrile, systemic, and zoonotic infectious disease caused by leptospira species. It is characterized by widespread vasculitis (1). Infection is transmitted to humans via the mucosal or percutaneous route after direct contact with infected animals or, more often, with leptospira-contaminated water or soil (2). Leptospirosis is frequently observed in irrigation workers, farmers, soldiers, miners, veterinarians, and sewer workers (1, 2). This more common infection, particularly in tropical regions, can also cause epidemics (3). In particular, waterborne outbreaks have been reported in Southeast Asia and America (4, 5). In our country, many patients are reported on a case-by-case basis (6-8).

Although the non-icteric form is seen in 90% of patients with leptospirosis, approximately 5-10% of patients have a severe form called Weil’s disease, which is characterized by fever, jaundice, bleeding, and fulminant hepatorenal insufficiency. This condition progresses with severe jaundice and hepatorenal failure and has a high mortality rate (9). A definitive diagnosis of the disease is made by the presence of clinical findings and positivity to serological tests or the isolation of leptospira in urine or blood. It is known that serological tests have low sensitivity for the diagnosis of leptospirosis. Some of these patients die without being diagnosed, whereas others remain undiagnosed and recover with non-specific disease treatments (10).

In this study, we aimed to investigate the clinical, laboratory, and epidemiological characteristics of 115 patients who were followed up for the diagnosis of leptospirosis in the Kızıltepe district of Mardin.

MATERIALS and METHODS

This retrospective and descriptive study was planned. The data on leptospirosis cases observed in Kızıltepe and Derik districts and their villages in Mardin province between 27 May 2019 and 28 July 2019 were retrospectively analyzed. The study was approved by the University of Health Sciences Turkey, Adana City Training and Research Hospital, Clinical Research Ethics Committee (decision number: 1799, date: 24.02.2022). A total of 115 patients who were hospitalized at Kızıltepe State Hospital or followed up for outpatient control were included in the study. The diagnosis of patients is based on either clinical diagnosis or serological test positivity. The clinical diagnosis depends on a history of exposure to infected animals or an environment/water that may be contaminated with animal urine, along with acute febrile illness that may be associated with any of the symptoms expected in leptospirosis like headache, myalgia, and exhaustion. The serodiagnosis of the disease in suspected patients was made by the leptospira microagglutination test (MAT), and a titer of ≥1/200 in a single serum sample or ≥4- fold increased titer in a double serum sample was considered positive. Accordingly, 62 patients with a clinical diagnosis and 53 patients with confirmed serology were identified. Basic demographic data on patients and characteristics of disease-specific clinical and laboratory findings were obtained from hospital registry records. Complete blood count, routine biochemical tests [aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma glutamil transferase, alkaline phosphatase, etc.] coagulation tests, erythrocyte sedimentation rate, C-reactive protein (CRP) levels, hepatitis indicators (hepatitis A immunoglobulin G, hepatitis B surface antigen, AntiHBs, hepatitis B surface antibody, hepatitis C antibody), and AntiHIV were requested from the patients. Also, 8-10 mL of venous blood was taken into yellow vacutainer tubes and centrifuged at 4000 rpm for 10 min to obtain sera for MAT investigations.

Statistical Analysis

The data were analyzed using the SPSS-22 package. Descriptive statistics were used in the evaluation of the data, and the data were presented as median [minimum-maximum (min-max) value], number, and percentage distribution.

RESULTS

The mean age of the patients evaluated in the current study was 29.4 years (min: 10, max: 65), and 96 (83.5%) of them were men. As 58.3% (n=67) of the patients were citizens of the Republic of Turkey, all other patients were Syrian citizens and lived in Turkey. In terms of occupational distribution, 108 (93.9%) patients worked as irrigation workers, and the other 7 (6.1%) were unemployed. When the geographical region where the patients live is studied; all of the patients were from Mardin province; 20 (17.4%) of them reside in Derik, 90 (78.3%) in Kızıltepe, and 5 (4.3%) resided in other districts.

43.6% (n=50) of the patients were hospitalized, whereas the others were followed up with outpatient clinic control. Five hospitalized patients were followed up in the intensive care unit. The disease was not fatal, and all patients were cured.

When the admission symptoms and symptoms developed during the clinical follow-up of the patients were examined, it was observed that all patients presented with fever. The distribution of other symptoms is presented in Table 1.

While hepatomegaly was the most common sign 31.3% (n=36), conjunctivitis, lymphadenopathy, and splenomegaly were other common findings. The distribution of all clinical signs is presented in Table 2.

Thrombocytopenia occurs in 73% of patients, and it is the most important laboratory finding. The mean laboratory findings were; white blood cell count 100032 mm³, of which neutrophils comprised 79%; ALT, 64 International units/liter (IU)/(L); AST, 72 IU/L; blood urea nitrogen, 17 mg/dL; creatinine, 1.11 mg/dL; total bilirubin, 1.8 mg/dL; creatine kinase, 381 IU/L; erythrocyte sedimentation rate, 32 mm/h; CRP, 99 mg/L, platelet (PLT )140000 mm³ at first admission; and lowest PLT 112000 mm³ at follow-up. The laboratory findings of the patients are summarized in Table 3.

Two therapeutic agents were used for patient treatment. Ceftriaxone was intravenously administered with a posology of 2x1 g in hospitalized patients, and doxycycline capsules were administered with an oral posology of 2x100 mg in outpatients. In the follow-up of patients in the intensive care unit, broad-spectrum antibiotics were required due to prolonged hospitalization and nosocomial infections. One patient with pulmonary hemorrhage was treated with methylprednisolone 250 mg/day for 3 days.

DISCUSSION

In our study, fever was the complaint of hospital admission in all of the patients who were agricultural workers. Most of them were of Syrian origin. The fact that no deaths were observed in these cases highlights the most important finding of our study. The coincidence of patient presentation to the epidemic period, consideration of leptospirosis in the differential diagnosis, and early commencement of antibiotic therapy are believed to contribute to this finding. In a retrospective case-control study conducted in New Caledonia, risk factors for the development of severe leptospirosis, in addition to infection due to Leptospira interrogans serogroup Icterohaemorrhagiae, were attributed to a delay in antibiotherapy initiation of >2 days following the onset of symptoms (11). The younger age of patients in our study may be another reason for the lack of mortality. Amilasan et al. (12) reported a 51% mortality rate that was also attributed to advanced age and delayed antibiotic therapy.

Rigors, headache, and myalgia follow fever in frequency, and they were commonly observed at similar rates as those reported in the literature. Conjunctival redness is another important but mostly overlooked sign; Vanasco et al. (13) reported that 55% of leptospirosis patients had conjunctival redness. We also found conjunctivitis in 8.7% of our patients; the reason for this inconsistency could be related to the lack of sub-conjunctival hemorrhage as a result of early treatment.

Splenomegaly, lymphadenopathy, hepatomegaly, skin rash, and jaundice were observed in our patients at rates comparable to those reported in similar studies in the literature (14, 15). In a study conducted by Leblebicioglu et al. (16) from our country, 12 cases were defined in the form of Weil’s disease, and they detected jaundice and myalgia in all of these patients. The reason why jaundice was less common in our cases could be that leptospirosis patients were diagnosed at an early stage before the development of Weil’s disease, and treatment was initiated at an early stage. The clinical findings of various studies reported from our country and the comparative data of our study are presented in Table 4.

Pulmonary manifestation with non-productive cough occurs in 25 to 35% of cases (14, 15). Pulmonary hemorrhage is a serious complication of leptospirosis; it may not be diagnosed adequately in highly endemic regions (18). Although cough complaints developed in our patients, pulmonary hemorrhage was seen only in 2 patients. None of them developed acute respiratory distress syndrome (ARDS). This might result from early diagnosis of the infection and early initiation of treatment. Comparable to the literature, we observed leukocytosis, left shift, thrombocytopenia, hepatic transaminase elevation, renal failure, and bilirubin elevation in our patients. Chierakul et al. (19) reported thrombocytopenia as one of the most prominent findings.

The mortality rates in hospitalized patients with leptospirosis ranged from 4% to 52% (12, 20). In Peru, 3.7% of 321 patients with serological and clinical evidence of leptospirosis had severe pulmonary manifestations; 71% of these manifestations resulted in death (causes include pulmonary hemorrhage, ARDS, and multiple organ failure) (21). In a retrospective review of 282 cases of leptospirosis during an outbreak in India, pulmonary involvement and central nervous system disease were identified as important predictors of death in logistic regression analysis (12). Although renal failure was present in one-fifth of our cases, the reasons why there was no death in our cases might be the early initiation of antimicrobial therapy, the absence of central nervous system involvement, and the low incidence of pulmonary hemorrhage, and thus the absence of ARDS.

Study Limitations

The limitations of our study are that the sample was limited to the region where the epidemic occurred and only reflected patients from a limited region. On the other hand, this is a powerful study in which a very high number of patients with leptospirosis were evaluated, and no mortality was observed.

CONCLUSION

As a result, leptospirosis remains a common zoonosis in tropical regions, especially among agricultural irrigation workers. The differential diagnosis of acute fever in endemic areas should be considered, and the epidemiological history of the area should be investigated. Considering the clinical and serological diagnosis of leptospirosis, initiating antibiotherapy early is of vital importance because it will reduce mortality.

References

1
Levett PN, Haake DA. Leptospira Species: Leptospirosis. In: Mandell GL, Bennett JE, Dolin R, editors, Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. 7th edition. Churchill-Livingstone, Philadelphia. 2010; 3059- 400
2
Vijayachari P, Sugunan AP, Shriram AN. Leptospirosis: an emerging global public health problem. J Biosci. 2008; 33(4): 557-69.
3
Costa F, Hagan JE, Calcagno J, Kane M, Torgerson P, Martinez-Silveira MS, et al. Global Morbidity and Mortality of Leptospirosis: A Systematic Review. PLoS Negl Trop Dis. 2015; 9(9): e0003898.
4
Sehgal SC, Sugunan AP, Vijayachari P. Outbreak of leptospirosis after the cyclone in Orissa. Natl Med J India. 2002; 15(1): 22-3
5
Pradutkanchana J, Pradutkanchana S, Kemapanmanus M, Wuthipum N, Silpapojakul K. The etiology of acute pyrexia of unknown origin in children after a flood. Southeast Asian J Trop Med Public Health. 2003; 34(1): 175-8
6
Büyükfırat E, Karahan MA, Altay N, Binici O, Binici İ, Sak ZHA. Icterohemorrhagic Leptospirosis: A Case Report. J Turk Soc Intens Care. 2019; 17(1): 49-53
7
Tetikkurt C, Yanardag H, Bilir M. Diagnosis of leptospirosis: a case report. Chest Dis Rep. 2023; 11(1)
8
Doneray H, Keskin H, Akat H, Basaslan IH, Bagatir PS. Pediatric Leptospirosis: A Case Report and Review of Literature. Eurasian J Med. 2023; 55(1): S150-6
9
Rajapakse S. Leptospirosis: clinical aspects. Clin Med (Lond). 2022; 22(1): 14-7.
10
Budihal SV, Perwez K. Leptospirosis diagnosis: competancy of various laboratory tests. J Clin Diagn Res. 2014; 8(1): 199-202.
11
Tubiana S, Mikulski M, Becam J, Lacassin F, Lefèvre P, Gourinat AC, et al. Risk factors and predictors of severe leptospirosis in New Caledonia. PLoS Negl Trop Dis. 2013; 7(1): e1991
12
Amilasan AS, Ujiie M, Suzuki M, Salva E, Belo MC, Koizumi N, et al. Outbreak of leptospirosis after flood, the Philippines, 2009. Emerg Infect Dis. 2012; 18(1): 91-4.
13
Vanasco NB, Schmeling MF, Lottersberger J, Costa F, Ko AI, Tarabla HD. Clinical characteristics and risk factors of human leptospirosis in Argentina (1999-2005). Acta Trop. 2008; 107(3): 255-8.
14
Sanford JP. Leptospirosis--time for a booster. N Engl J Med. 1984; 310(8): 524-5.
15
Berman SJ, Tsai CC, Holmes K, Fresh JW, Watten RH. Sporadic anicteric leptospirosis in South Vietnam. A study in 150 patients. Ann Intern Med. 1973; 79(2): 167-73.
16
Leblebicioglu H, Sencan I, Sünbül M, Altintop L, Günaydin M. Weil’s disease: report of 12 cases. Scand J Infect Dis. 1996; 28(6): 637-9.
17
Turhan V, Polat E, Murat Atasoyu E, Ozmen N, Kucukardali Y, Cavuslu S. Leptospirosis in Istanbul, Turkey: a wide spectrum in clinical course and complications. Scandinavian journal of infectious diseases. 2006; 38(10), 845-52.https://doi.org/10.1080/00365540600681542.
18
Ebrahimi R. Çukurova bölgesinde leptospirozis insidansı. Çukurova Üniverstesi Tıp Fakültesi Doktora Tezi. Adana. 1995.
19
Assimakopoulos SF, Fligou F, Marangos M, Zotou A, Psilopanagioti A, Filos KS. Anicteric leptospirosis-associated severe pulmonary hemorrhagic syndrome: a case series study. Am J Med Sci. 2012; 344(4): 326-9.
20
Chierakul W, Tientadakul P, Suputtamongkol Y, Wuthiekanun V, Phimda K, Limpaiboon R, et al. Activation of the coagulation cascade in patients with leptospirosis. Clin Infect Dis. 2008; 46(2): 254-60.
21
Pappachan MJ, Mathew S, Aravindan KP, Khader A, Bharghavan PV, Kareem MM, et al. Risk factors for mortality in patients with leptospirosis during an epidemic in northern Kerala. Natl Med J India. 2004; 17(5): 240-2.
22
Segura ER, Ganoza CA, Campos K, Ricaldi JN, Torres S, Silva H, et al. Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis. 2005; 40(3): 343-51.